Compare Alphabet Inc Class A (GOOGL) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alphabet Inc Class A vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Alphabet Inc Class A trades at $351.66 (market cap $4.24T), while Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B). The key difference: Alphabet Inc Class A is far larger — about 337× Halozyme Therapeutics Inc. Common Stock's market cap, and Alphabet Inc Class A pays a 0.25% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Alphabet Inc Class A for 85 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| GOOGL | HALO | |
|---|---|---|
Market Cap | $4.24T | $12.58B |
Volume | 23,392,850 | 2,179,278 |
Sector | Media | Health |
52-Week High | $402.62 | $115.22 |
52-Week Low | $236.59 | $61.63 |
Typical Hold Time | 85 Days | 1 Days |
Enterprise Value | $4.13T | $14.49B |
Dividend Yield | 0.25% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Alphabet (GOOGL) trades at $348.29, down 0.63% on the day, with strong technical support at $346 and resistance at $352. The company demonstrates robust fundamentals with 2025 revenue of $402.84B and net income of $132.17B, achieving a 32.8% profit margin. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $9.11 surpassing the $2.87 estimate. Analyst consensus remains overwhelmingly bullish with 87% buy ratings and a $431.83 price target, representing 24% upside potential.
Alphabet presents a compelling investment case driven by AI leadership, strong cash flow generation, and consistent earnings outperformance. Key risks include regulatory scrutiny, competitive pressures in search and cloud, and market volatility. The stock's current valuation at 17.48x P/E appears reasonable given growth prospects, while technical indicators suggest near-term consolidation within a defined trading range.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alphabet Inc Class A
Alphabet, the parent company of Google, earns nearly 90% of its revenue from Google services, mainly through advertising. Other revenue comes from subscriptions (YouTube TV, YouTube Music), platform sales (Play Store purchases), and devices (Pixel, Chromebooks, Chromecast). Google Cloud contributes around 10%, while investments in self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) make up the rest.
Read more on GOOGL →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
